Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer

Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer

Background: Bacillus Calmette-Guérin (BCG) immunotherapy, the standard adjuvant intravesical therapy for some intermediate and most high-risk non-muscle invasive bladder cancers (NMIBCs), suffers from a heterogenous response rate. Molecular markers to help guide responses are scarce and currently no...

Full description

Bibliographic Details
Main Authors:	Dafina Ilijazi, Walter Pulverer, Iris E. Ertl, Ursula Lemberger, Shoji Kimura, Mohammad Abufaraj, David D’Andrea, Benjamin Pradere, Andreas Bruchbacher, Anna Graf, Francesco Soria, Martin Susani, Andrea Haitel, Luca Molinaro, Armin Pycha, Evi Comploj, Stephan Pabinger, Andreas Weinhäusel, Gerda Egger, Shahrokh F. Shariat, Melanie R. Hassler
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Cells
Subjects:	bladder cancer Bacillus Calmette-Guérin DNA methylation marker urothelial cancer Illumina MethylationEPIC BeadChip high-risk bladder cancer
Online Access:	https://www.mdpi.com/2073-4409/9/8/1839

Similar Items

Intravesical immunotherapy in nonmuscle invasive bladder cancer
by: Jan-Friedrich Jokisch, et al.
Published: (2015-01-01)

Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
by: Nassib Abou Heidar, et al.
Published: (2021-03-01)

Bacillus Calmette-Guérin pneumonitis after intravesical instillation: Report of two cases and a review of the literature
by: Martina Spisarova, et al.
Published: (2024-06-01)

A case of post-BCG therapy renal granuloma concurrent with ureteral carcinoma
by: Tatsuya Otaki, et al.
Published: (2023-03-01)

Granulomatous Hepatitis Following Intra-Vesical Instillation of Bacillus Calmette–Guérin for Treatment of Bladder Cancer
by: Elsa Alves Branco, et al.
Published: (2021-07-01)

Single course of intravesical Bacillus Calmette–Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study
by: Mohamed Bakr Mohamed, et al.
Published: (2020-01-01)

Blood-based epigenetic estimators of chronological age in human adults using DNA methylation data from the Illumina MethylationEPIC array
by: Yunsung Lee, et al.
Published: (2020-10-01)

Efficacy of bladder instillations with mitomycin or bacillus Calmette–Guérin in patients with T1 high-grade bladder cancer: Experience from a single center
by: Li-Wen Chang, et al.
Published: (2019-01-01)

Antibiotic therapy impact on intravesical BCG therapy efficacy for high-risk localized bladder cancer treatment
by: Cécile Aubert, et al.
Published: (2024-03-01)

Bacillus Calmette-Guerin Increases Base Excision Repair in Bladder Cancer Cells
by: Selçuk Keskin, et al.
Published: (2021-03-01)

Gluteal abscess: An unusual complication of Bacille Calmette-Guérin
by: Hakan Buyukoglan, et al.
Published: (2011-01-01)

A randomized trial comparing low dose (40 or 80 mg) with standard dose (120 mg) of bacillus Calmette-Guerin for superficial bladder cancer
by: Vivek Vijjan, et al.
Published: (2006-01-01)

Regression of the Sweet's syndrome after Bacillus Calmette-Guérin therapy: A bladder cancer case report
by: İbrahim Halil Baloglu, et al.
Published: (2020-07-01)

The impact of low input DNA on the reliability of DNA methylation as measured by the Illumina Infinium MethylationEPIC BeadChip
by: Sarah Holmes Watkins, et al.
Published: (2022-12-01)

Stability selection enhances feature selection and enables accurate prediction of gestational age using only five DNA methylation sites
by: Kristine L. Haftorn, et al.
Published: (2023-07-01)

Impact of maintenance therapy using a half dose of the bacillus Calmette–Guérin Tokyo strain on recurrence of intermediate and high-risk nonmuscle invasive bladder cancer: a retrospective single-center study
by: Dai Koguchi, et al.
Published: (2020-12-01)

Maintenance bacillus Calmette–Guérin therapy prolongs recurrence-free survival in non-muscle-invasive bladder cancer: A real-world experience
by: Chung-Yi Liu, et al.
Published: (2015-06-01)

Treatment of high-risk non-muscle invasive bladder cancer: current status and prospect
by: SHEN Yijun, et al.
Published: (2021-12-01)

Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy
by: Guven Aslan, et al.
Published: (2013-01-01)

Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
by: Michael E. Rezaee, et al.
Published: (2021-04-01)

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

Identification of polymorphic and off-target probe binding sites on the Illumina Infinium MethylationEPIC BeadChip
by: Daniel L. McCartney, et al.
Published: (2016-09-01)

Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial
by: Christine G.J.I. van Straten, et al.
Published: (2023-10-01)

Intravesical ALT-803 for BCG-unresponsive Bladder Cancer – A Case Report
by: Jeffrey Huang, et al.
Published: (2017-09-01)

Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
by: R. Waked, et al.
Published: (2020-05-01)

Tuberculosis Epididymo-Orchitis Mimicking Malignancy Resulting from Intravesical Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: A Case Report of a Rare Complication
by: Liang-Wei Chiu, et al.
Published: (2022-11-01)

The natural course of bacillus Calmette-Guérin induced bladder lesions: A long-term follow-up study and systematic review
by: Chong Ma, et al.
Published: (2023-07-01)

Impact of Reducing Irritative Symptoms in Non-Muscle Invasive Bladder Cancer During BCG Instillation: A Pilot Study
by: Osman Köse, et al.
Published: (2020-12-01)

Recurrence and progression in nonmuscle invasive transitional cell carcinoma of urinary bladder treated with intravesical Bacillus Calmette–Guerin: A single center experience and analysis of prognostic factors
by: Shouki N Bazarbashi, et al.
Published: (2016-01-01)

New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis
by: Katia Pane, et al.
Published: (2020-07-01)

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
by: Chun Jye Lim, et al.
Published: (2021-01-01)

Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications
by: Magdalene Joseph, et al.
Published: (2019-11-01)

A review on the evolution of immunotherapy in bladder carcinoma
by: Milena Gulinac, et al.
Published: (2020-10-01)

Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette–Guérin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis
by: Zhiyong Cai, et al.
Published: (2021-06-01)

Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
by: Sahyun Pak, et al.
Published: (2021-04-01)

Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette-Guérin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective comparison
by: Teruo Inamoto, et al.
Published: (2013-01-01)

A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer
by: Girish S. Kulkarni, et al.
Published: (2022-07-01)

Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature
by: Oreoluwa Oladiran, et al.
Published: (2020-03-01)

Examining Sexual Dysfunction in Non‐Muscle‐Invasive Bladder Cancer: Results of Cross‐Sectional Mixed‐Methods Research
by: Marc A. Kowalkowski, PhD, et al.
Published: (2014-08-01)

Saudi urologists’ treatment pattern for high-risk Bacillus Calmette–Guérin naïve and Bacillus Calmette–Guérin unresponsive nonmuscle invasive bladder cancer
by: Mohammad Alghafees, et al.
Published: (2025-01-01)